243 related articles for article (PubMed ID: 22352988)
1. Temporal pattern and costs of rehospitalization in atrial fibrillation/atrial flutter patients with one or more additional risk factors.
Amin AN; Jhaveri M; Lin J
J Med Econ; 2012; 15(3):548-55. PubMed ID: 22352988
[TBL] [Abstract][Full Text] [Related]
2. Hospital readmissions in US atrial fibrillation patients: occurrence and costs.
Amin AN; Jhaveri M; Lin J
Am J Ther; 2013; 20(2):143-50. PubMed ID: 23183097
[TBL] [Abstract][Full Text] [Related]
3. Incremental cost burden to US healthcare payers of atrial fibrillation/atrial flutter patients with additional risk factors.
Amin AN; Jhaveri M; Lin J
Adv Ther; 2011 Oct; 28(10):907-26. PubMed ID: 21971681
[TBL] [Abstract][Full Text] [Related]
4. CHADS2 and CHA2DS2-VASc risk factors to predict first cardiovascular hospitalization among atrial fibrillation/atrial flutter patients.
Naccarelli GV; Panaccio MP; Cummins G; Tu N
Am J Cardiol; 2012 May; 109(10):1526-33. PubMed ID: 22360819
[TBL] [Abstract][Full Text] [Related]
5. Rhythm- and rate-controlling effects of dronedarone in patients with atrial fibrillation (from the ATHENA trial).
Page RL; Connolly SJ; Crijns HJ; van Eickels M; Gaudin C; Torp-Pedersen C; Hohnloser SH;
Am J Cardiol; 2011 Apr; 107(7):1019-22. PubMed ID: 21296333
[TBL] [Abstract][Full Text] [Related]
6. Cost burden of cardiovascular hospitalization and mortality in ATHENA-like patients with atrial fibrillation/atrial flutter in the United States.
Naccarelli GV; Johnston SS; Lin J; Patel PP; Schulman KL
Clin Cardiol; 2010 May; 33(5):270-9. PubMed ID: 20513065
[TBL] [Abstract][Full Text] [Related]
7. Atrial fibrillation or flutter on initial electrocardiogram is associated with worse outcomes in patients admitted for worsening heart failure with reduced ejection fraction: findings from the EVEREST Trial.
Mentz RJ; Chung MJ; Gheorghiade M; Pang PS; Kwasny MJ; Ambrosy AP; Vaduganathan M; O'Connor CM; Swedberg K; Zannad F; Konstam MA; Maggioni AP
Am Heart J; 2012 Dec; 164(6):884-92.e2. PubMed ID: 23194489
[TBL] [Abstract][Full Text] [Related]
8. Incidence, risk factors, and clinical outcomes of atrial fibrillation and atrial flutter after heart transplantation.
Dasari TW; Pavlovic-Surjancev B; Patel N; Williams AA; Ezidinma P; Rupani A; Sinacore JL; Heroux AL
Am J Cardiol; 2010 Sep; 106(5):737-41. PubMed ID: 20723655
[TBL] [Abstract][Full Text] [Related]
9. Impact of dronedarone treatment on healthcare resource utilization in patients with atrial fibrillation/flutter.
Kim MH; Lin J; Jhaveri M; Koren A
Adv Ther; 2014 Mar; 31(3):318-32. PubMed ID: 24595638
[TBL] [Abstract][Full Text] [Related]
10. Prevalence, pathophysiology, and clinical significance of post-heart transplant atrial fibrillation and atrial flutter.
Ahmari SA; Bunch TJ; Chandra A; Chandra V; Ujino K; Daly RC; Kushwaha SS; Edwards BS; Maalouf YF; Seward JB; McGregor CG; Chandrasekaran K
J Heart Lung Transplant; 2006 Jan; 25(1):53-60. PubMed ID: 16399531
[TBL] [Abstract][Full Text] [Related]
11. Rates and implications for hospitalization of patients ≥65 years of age with atrial fibrillation/flutter.
Naccarelli GV; Johnston SS; Dalal M; Lin J; Patel PP
Am J Cardiol; 2012 Feb; 109(4):543-9. PubMed ID: 22118826
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of isolated atrial flutter versus atrial flutter combined with atrial fibrillation.
Peyrol M; Sbragia P; Bonello L; Lévy S; Paganelli F
Arch Cardiovasc Dis; 2011 Oct; 104(10):530-5. PubMed ID: 22044706
[TBL] [Abstract][Full Text] [Related]
13. Readmissions and repeat procedures after catheter ablation for atrial fibrillation.
Opolski G; Januszkiewicz Ł; Szczerba E; Osińska B; Rutkowski D; Kalarus Z; Kaźmierczak J
Cardiol J; 2015; 22(6):630-6. PubMed ID: 26100826
[TBL] [Abstract][Full Text] [Related]
14. [The effects of the ablation of atrial flutter in patients with and without a clinical history of paroxysmal atrial fibrillation].
De Sisti A; Leclercq JF; Fiorello P; Palamara A; Attuel P
G Ital Cardiol; 1998 Nov; 28(11):1253-60. PubMed ID: 9866803
[TBL] [Abstract][Full Text] [Related]
15. Results of atrial fibrillation ablation during mitral surgery in patients with poor electro-anatomical substrate.
Onorati F; Rubino AS; Mariscalco G; Serraino F; Sala A; Renzulli A
J Heart Valve Dis; 2009 Nov; 18(6):607-16. PubMed ID: 20099709
[TBL] [Abstract][Full Text] [Related]
16. Cost of atrial fibrillation in United States managed care organizations.
Kim MH; Lin J; Hussein M; Kreilick C; Battleman D
Adv Ther; 2009 Sep; 26(9):847-57. PubMed ID: 19768638
[TBL] [Abstract][Full Text] [Related]
17. Higher rate of recurrent atrial flutter and atrial fibrillation following atrial flutter ablation after cardiac surgery.
Aktas MK; Khan MN; Di Biase L; Elayi C; Martin D; Saliba W; Cummings J; Schweikert R; Natale A
J Cardiovasc Electrophysiol; 2010 Jul; 21(7):760-5. PubMed ID: 20132385
[TBL] [Abstract][Full Text] [Related]
18. Estimation of potential cost savings associated with reduced rates of cardiovascular hospitalization among atrial fibrillation/flutter patients treated with dronedarone in the ATHENA trial.
Reynolds MR; Lin J; Jhaveri M; Mozaffari E; Plich A
Am J Ther; 2014; 21(6):500-8. PubMed ID: 23344106
[TBL] [Abstract][Full Text] [Related]
19. Increasing prevalence of atrial fibrillation and flutter in the United States.
Naccarelli GV; Varker H; Lin J; Schulman KL
Am J Cardiol; 2009 Dec; 104(11):1534-9. PubMed ID: 19932788
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of dronedarone in patients with a prior ablation for atrial fibrillation/flutter: Insights from the ATHENA study.
Vamos M; Calkins H; Kowey PR; Torp-Pedersen CT; Corp Dit Genti V; Wieloch M; Koren A; Hohnloser SH
Clin Cardiol; 2020 Mar; 43(3):291-297. PubMed ID: 31872901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
